Frequency of self-monitoring blood glucose and attainment of HbA1c target values

Autores
Elgart, Jorge Federico; González, Lorena; Prestes, Mariana; Rucci, Enzo; Gagliardino, Juan José
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Aims. Test strips for self-monitoring of blood glucose (SMBG) represent in Argentina, around 50 % of diabetes treatment cost; the frequency of their use is closely associated with hyperglycemia treatment. However, the favorable impact of SMBG on attainment of HbA1c goal in different treatment conditions remains controversial. We therefore attempted to estimate the relationship between use of SMBG test strips and degree of attainment of metabolic control in an institution of our social security subsector (SSS) in which provision is fully covered and submitted to a regular audit system. Methods. Observational retrospective study using information of 657 patients with T2DM (period 2009–2010) from the database of the Diabetes and Other Cardiovascular Risk Factors Program (DICARO) of one institution of our SSS. DICARO provides—with an audit system—100 % coverage for all drugs and keeps records of clinical, metabolic and treatment data from every patient. Results. The average monthly test strips/patient used for SMBG increased as a function of treatment intensification: Monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. In every condition, the number was larger in people with target HbA1c levels. Test strips represented the larger percentage of total prescription cost. Conclusions. In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG; in every condition tested, targeted HbA1c values were associated with greater strip use. Patient education and prescription audit may optimize its use and treatment outcomes.
Centro de Endocrinología Experimental y Aplicada
Facultad de Ciencias Económicas
Instituto de Investigación en Informática
Materia
Medicina
SMBG
Metabolic control
Treatment costs
Diabetes education
Prescription audit
Treatment targets
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/139180
Acceder
id SEDICI_8a6a8aa662c9a2b92075e4a2ae965d38
oai_identifier_str oai:sedici.unlp.edu.ar:10915/139180
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Frequency of self-monitoring blood glucose and attainment of HbA1c target valuesElgart, Jorge FedericoGonzález, LorenaPrestes, MarianaRucci, EnzoGagliardino, Juan JoséMedicinaSMBGMetabolic controlTreatment costsDiabetes educationPrescription auditTreatment targetsAims. Test strips for self-monitoring of blood glucose (SMBG) represent in Argentina, around 50 % of diabetes treatment cost; the frequency of their use is closely associated with hyperglycemia treatment. However, the favorable impact of SMBG on attainment of HbA1c goal in different treatment conditions remains controversial. We therefore attempted to estimate the relationship between use of SMBG test strips and degree of attainment of metabolic control in an institution of our social security subsector (SSS) in which provision is fully covered and submitted to a regular audit system. Methods. Observational retrospective study using information of 657 patients with T2DM (period 2009–2010) from the database of the Diabetes and Other Cardiovascular Risk Factors Program (DICARO) of one institution of our SSS. DICARO provides—with an audit system—100 % coverage for all drugs and keeps records of clinical, metabolic and treatment data from every patient. Results. The average monthly test strips/patient used for SMBG increased as a function of treatment intensification: Monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. In every condition, the number was larger in people with target HbA1c levels. Test strips represented the larger percentage of total prescription cost. Conclusions. In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG; in every condition tested, targeted HbA1c values were associated with greater strip use. Patient education and prescription audit may optimize its use and treatment outcomes.Centro de Endocrinología Experimental y AplicadaFacultad de Ciencias EconómicasInstituto de Investigación en Informática2016-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf57-62http://sedici.unlp.edu.ar/handle/10915/139180enginfo:eu-repo/semantics/altIdentifier/issn/1432-5233info:eu-repo/semantics/altIdentifier/issn/0940-5429info:eu-repo/semantics/altIdentifier/doi/10.1007/s00592-015-0745-9info:eu-repo/semantics/altIdentifier/pmid/25841589info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/Creative Commons Attribution 4.0 International (CC BY 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-03T11:04:09Zoai:sedici.unlp.edu.ar:10915/139180Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-03 11:04:09.562SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Frequency of self-monitoring blood glucose and attainment of HbA1c target values
title Frequency of self-monitoring blood glucose and attainment of HbA1c target values
spellingShingle Frequency of self-monitoring blood glucose and attainment of HbA1c target values
Elgart, Jorge Federico
Medicina
SMBG
Metabolic control
Treatment costs
Diabetes education
Prescription audit
Treatment targets
title_short Frequency of self-monitoring blood glucose and attainment of HbA1c target values
title_full Frequency of self-monitoring blood glucose and attainment of HbA1c target values
title_fullStr Frequency of self-monitoring blood glucose and attainment of HbA1c target values
title_full_unstemmed Frequency of self-monitoring blood glucose and attainment of HbA1c target values
title_sort Frequency of self-monitoring blood glucose and attainment of HbA1c target values
dc.creator.none.fl_str_mv Elgart, Jorge Federico
González, Lorena
Prestes, Mariana
Rucci, Enzo
Gagliardino, Juan José
author Elgart, Jorge Federico
author_facet Elgart, Jorge Federico
González, Lorena
Prestes, Mariana
Rucci, Enzo
Gagliardino, Juan José
author_role author
author2 González, Lorena
Prestes, Mariana
Rucci, Enzo
Gagliardino, Juan José
author2_role author
author
author
author
dc.subject.none.fl_str_mv Medicina
SMBG
Metabolic control
Treatment costs
Diabetes education
Prescription audit
Treatment targets
topic Medicina
SMBG
Metabolic control
Treatment costs
Diabetes education
Prescription audit
Treatment targets
dc.description.none.fl_txt_mv Aims. Test strips for self-monitoring of blood glucose (SMBG) represent in Argentina, around 50 % of diabetes treatment cost; the frequency of their use is closely associated with hyperglycemia treatment. However, the favorable impact of SMBG on attainment of HbA1c goal in different treatment conditions remains controversial. We therefore attempted to estimate the relationship between use of SMBG test strips and degree of attainment of metabolic control in an institution of our social security subsector (SSS) in which provision is fully covered and submitted to a regular audit system. Methods. Observational retrospective study using information of 657 patients with T2DM (period 2009–2010) from the database of the Diabetes and Other Cardiovascular Risk Factors Program (DICARO) of one institution of our SSS. DICARO provides—with an audit system—100 % coverage for all drugs and keeps records of clinical, metabolic and treatment data from every patient. Results. The average monthly test strips/patient used for SMBG increased as a function of treatment intensification: Monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. In every condition, the number was larger in people with target HbA1c levels. Test strips represented the larger percentage of total prescription cost. Conclusions. In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG; in every condition tested, targeted HbA1c values were associated with greater strip use. Patient education and prescription audit may optimize its use and treatment outcomes.
Centro de Endocrinología Experimental y Aplicada
Facultad de Ciencias Económicas
Instituto de Investigación en Informática
description Aims. Test strips for self-monitoring of blood glucose (SMBG) represent in Argentina, around 50 % of diabetes treatment cost; the frequency of their use is closely associated with hyperglycemia treatment. However, the favorable impact of SMBG on attainment of HbA1c goal in different treatment conditions remains controversial. We therefore attempted to estimate the relationship between use of SMBG test strips and degree of attainment of metabolic control in an institution of our social security subsector (SSS) in which provision is fully covered and submitted to a regular audit system. Methods. Observational retrospective study using information of 657 patients with T2DM (period 2009–2010) from the database of the Diabetes and Other Cardiovascular Risk Factors Program (DICARO) of one institution of our SSS. DICARO provides—with an audit system—100 % coverage for all drugs and keeps records of clinical, metabolic and treatment data from every patient. Results. The average monthly test strips/patient used for SMBG increased as a function of treatment intensification: Monotherapy with oral antidiabetic drugs (OAD) < combined OAD therapy < insulin treatment. In every condition, the number was larger in people with target HbA1c levels. Test strips represented the larger percentage of total prescription cost. Conclusions. In our population, the type of hyperglycemia treatment was the main driver of test strip use for SMBG; in every condition tested, targeted HbA1c values were associated with greater strip use. Patient education and prescription audit may optimize its use and treatment outcomes.
publishDate 2016
dc.date.none.fl_str_mv 2016-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/139180
url http://sedici.unlp.edu.ar/handle/10915/139180
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1432-5233
info:eu-repo/semantics/altIdentifier/issn/0940-5429
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00592-015-0745-9
info:eu-repo/semantics/altIdentifier/pmid/25841589
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.format.none.fl_str_mv application/pdf
57-62
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1842260540225748992
score 13.13397

Publicaciones similares